Login / Signup

Experiences using a progestin-only pill in an over-the-counter environment in the United States: a cross-sectional survey.

Kate GrindlayKatherine KeyCarmela ZunigaAlexandra WollumDaniel GrossmanKelly Blanchard
Published in: BMJ sexual & reproductive health (2022)
Overall, OTC POP users in a trial setting found the menstrual bleeding acceptable and the method similar to or better than previous methods. POP labelling should provide clear messaging about bleeding changes users may experience.
Keyphrases
  • atrial fibrillation
  • study protocol
  • clinical trial
  • phase iii
  • mental health
  • phase ii
  • smoking cessation